Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
about
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancerImmunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAFDetection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevanceThe androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancerQuantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosisExpression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal statusExpression of androgen receptor and prostate-specific antigen in male breast carcinomaExpression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissueCodon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancerKallikrein gene downregulation in breast cancer.Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signalingmiR-320a is an independent prognostic biomarker for invasive breast cancerThe expression of prostate-specific antigen in invasive breast carcinoma and its relationship with routine clinicopathologic parameters.Prostate-specific antigen in serum of women with breast cancerImmunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicatorsProstate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumoursSteroid hormone regulation of prostate-specific antigen gene expression in breast cancer.Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancerAssociations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancerThe promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretionsSerum complexed and free prostate specific antigen levels are lower in female elite athletes in comparison to control women.Expression of prostate specific antigen in male breast cancer.
P2860
Q24642830-81B6A0E3-E315-4B89-805E-F607BB30665FQ24645388-BE44F0C7-8C9C-4760-9806-C12CF89CCBE8Q24646761-74D19477-ECDC-4F18-A1D8-8F2C53725143Q24646770-0BAFE5CF-44FA-411D-84C3-192B3FBD1E63Q24646799-51689331-1623-45EB-BF7E-51E127678CF4Q24652262-CD1989A7-3CF2-4772-AF53-FE2A773F3812Q24803812-54563F4B-D55B-4768-99F6-6E9C51892EAFQ28344337-C24AE3AC-FA78-467E-BEC8-3781DA4759A0Q28360883-913BD938-C8A6-41AF-B926-B43F6F177263Q30438640-B587A1CB-7CCA-4FB4-AE75-2162E231BEDFQ33382997-037CC746-E76C-466D-9DA1-FB64865253A0Q33712426-4C333296-6212-4520-8F9E-3EF55094A7BDQ33966915-3FB8A614-7989-44CB-BD5F-8034C26FE2FBQ33967807-65099A13-128D-4DDE-B9F2-266029AA48A8Q34552414-8742E2F5-950F-488F-8F11-F2A41CC2C1BBQ36081111-CB542C88-0D07-445C-87FC-44FCF2D00EDAQ36081213-B6891100-77AC-40ED-90C6-E89B60A5B95BQ36115207-BE93694D-57B8-46C7-A220-C237DED127FCQ36116069-792D231B-3138-4E0A-AA5A-4B0CA775A85CQ36136069-7CD8DA58-13BD-4F47-849E-13C4FE32A8E0Q36138971-C28ED713-F663-4E69-8E85-7CA56076948CQ36618953-AB7967A8-18DC-4A4A-9CF7-32EA11FD8C8FQ36619043-356B5C25-5957-41F2-AFDD-3357912C8F4CQ36619164-7F0B5D79-3077-4F54-951B-D54F2EA22D3FQ36619873-52D31EE5-1E8E-4874-849C-1D869422DC2EQ36621078-3BD35CC3-7236-414C-9BB1-8579918CEA4DQ41208085-EF9BE170-8540-496C-B564-4E45C30C1C76Q43010376-B9BCCE7F-04AC-4B8B-BF12-7D4D13C6085B
P2860
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Prostate-specific antigen is a ...... for women with breast cancer.
@en
Prostate-specific antigen is a ...... for women with breast cancer.
@nl
type
label
Prostate-specific antigen is a ...... for women with breast cancer.
@en
Prostate-specific antigen is a ...... for women with breast cancer.
@nl
prefLabel
Prostate-specific antigen is a ...... for women with breast cancer.
@en
Prostate-specific antigen is a ...... for women with breast cancer.
@nl
P2093
P1433
P1476
Prostate-specific antigen is a ...... r for women with breast cancer
@en
P2093
Diamandis EP
Katsaros D
Levesque MA
Sismondi P
Sutherland DJ
P304
P407
P577
1995-05-01T00:00:00Z